Interchange Capital Partners LLC Buys New Holdings in Colgate-Palmolive (NYSE:CL)

Interchange Capital Partners LLC bought a new stake in Colgate-Palmolive (NYSE:CLFree Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 2,375 shares of the company’s stock, valued at approximately $230,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Mitchell Sinkler & Starr PA raised its holdings in Colgate-Palmolive by 92.6% in the fourth quarter. Mitchell Sinkler & Starr PA now owns 45,899 shares of the company’s stock valued at $3,659,000 after acquiring an additional 22,073 shares in the last quarter. Stonehage Fleming Financial Services Holdings Ltd increased its stake in Colgate-Palmolive by 57.1% in the fourth quarter. Stonehage Fleming Financial Services Holdings Ltd now owns 383,819 shares of the company’s stock valued at $30,594,000 after purchasing an additional 139,429 shares during the last quarter. D L Carlson Investment Group Inc. purchased a new position in Colgate-Palmolive in the fourth quarter valued at approximately $3,269,000. Diversify Advisory Services LLC purchased a new position in Colgate-Palmolive in the first quarter valued at approximately $911,000. Finally, TD Asset Management Inc increased its stake in Colgate-Palmolive by 2.4% in the first quarter. TD Asset Management Inc now owns 1,154,566 shares of the company’s stock valued at $103,969,000 after purchasing an additional 26,987 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Insider Activity at Colgate-Palmolive

In related news, insider Sally Massey sold 15,850 shares of Colgate-Palmolive stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total value of $1,636,988.00. Following the transaction, the insider now directly owns 13,942 shares in the company, valued at approximately $1,439,929.76. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the firm’s stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total value of $1,636,988.00. Following the completion of the sale, the insider now owns 13,942 shares of the company’s stock, valued at $1,439,929.76. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Panagiotis Tsourapas sold 14,794 shares of the firm’s stock in a transaction on Thursday, August 8th. The shares were sold at an average price of $102.94, for a total value of $1,522,894.36. Following the completion of the sale, the insider now directly owns 5,146 shares of the company’s stock, valued at approximately $529,729.24. The disclosure for this sale can be found here. Insiders have sold a total of 43,490 shares of company stock worth $4,486,063 in the last three months. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $106.50 on Monday. The firm’s fifty day moving average price is $100.11 and its 200 day moving average price is $93.75. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $106.72. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.70. The firm has a market cap of $87.38 billion, a price-to-earnings ratio of 33.70, a price-to-earnings-growth ratio of 3.73 and a beta of 0.39.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its quarterly earnings data on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The firm had revenue of $5.06 billion for the quarter, compared to analyst estimates of $5 billion. During the same period last year, the firm posted $0.77 EPS. Colgate-Palmolive’s quarterly revenue was up 4.9% on a year-over-year basis. On average, sell-side analysts expect that Colgate-Palmolive will post 3.57 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Friday, July 19th were given a $0.50 dividend. The ex-dividend date was Friday, July 19th. This represents a $2.00 dividend on an annualized basis and a yield of 1.88%. Colgate-Palmolive’s dividend payout ratio (DPR) is 63.29%.

Analyst Ratings Changes

Several equities analysts have commented on CL shares. Stifel Nicolaus increased their price target on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a research note on Monday, July 22nd. Hsbc Global Res lowered shares of Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 26th. Deutsche Bank Aktiengesellschaft increased their price target on shares of Colgate-Palmolive from $104.00 to $107.00 and gave the company a “buy” rating in a research note on Monday, July 29th. Redburn Atlantic upgraded shares of Colgate-Palmolive to a “hold” rating in a research note on Thursday, August 1st. Finally, Jefferies Financial Group lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their price target for the company from $103.00 to $95.00 in a research note on Wednesday, July 24th. Eight investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $101.11.

Check Out Our Latest Research Report on Colgate-Palmolive

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.